'Brewcastle' beer trail maps out city's quest to quench tourism thirst The interactive beer trail map will be launched this week. Newcastle Herald · Sep 24, 2024
Dark vs Dark: cheers to craft beer's darker side "Buy your ticket, come in and you'll be well looked after." Newcastle Herald · Jul 17, 2024
FogHorn brewery ownership reaches full fermentation for Sherlock Sherlock unveils local focus for Newcastle craft beer mecca. Newcastle Herald · May 30, 2024
3 Biotech Stocks Climbing the Ranks to Watch The biotech industry is thriving on growing applications across sectors from healthcare to agriculture, favorable government funding and policies, and technological breakthroughs. Amid this backdrop, quality biotech stocks UroGen Pharma (URGN), Foghorn Therapeutics (FHTX), and Galapagos (GLPG) might be ideal additions to one’s watchlist. Read on…. StockNews.com · Mar 1, 2024
Newcastle food and wine take centre stage at Newcastle Food Month More than 40 feature events and over 50 plate specials during April Newcastle Herald · Feb 7, 2024
Thirsty work brews up golden batch at beer awards All the winners from the Australian International Beer Awards. Newcastle Herald · May 26, 2023
Beer Fest tapped for thirst-quenching return Take a look at what the brewers will be serving. Newcastle Herald · Feb 16, 2023
Building up Thirsty Messiah to sate beer dreams THOMAS Delgatto has been brewing beer for close to 40 years. It's been one helluva wait to realise his brewpub dream. The wait has been made even longer by a drawn-out City Of Newcastle development approval process for Delgatto's Broadmeadow venue, situated on Lambton Road in the former KTM Newcastle… Newcastle Herald · Nov 5, 2022
Bitter & Twisted hops back into frothing Hunter beer scene IT'S an understatement of monumental proportions to say plenty has happened in the world since the Bitter Twisted Boutique Beer Festival was last held in 2019. Newcastle Herald · Oct 31, 2022
Brewery collaboration delivers frothing result There's no territorial competition when it comes to good beer. Newcastle Herald · Aug 26, 2022
FDA Places Clinical Hold On Foghorn Therapeutics' Early-Stage Blood Cancer Trial The FDA has instituted a clinical hold on Foghorn Therapeutics Inc's (NASDAQ:FHTX) Phase 1 dose-escalation study of FHD-286 in relapsed and/or refractory acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). The FDA initiated the partial clinical hold following the report of a recent death that occurred in a subject with potential differentiation syndrome. Differentiation… Benzinga · May 20, 2022